Handelsbanken Fonder AB Sells 800 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR)
Handelsbanken Fonder AB trimmed its position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 4.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,500 shares of the company’s stock after selling 800 shares during the period. Handelsbanken Fonder AB’s […]
Handelsbanken Fonder AB trimmed its position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 4.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,500 shares of the company’s stock after selling 800 shares during the period. Handelsbanken Fonder AB’s […]
